Compare UVSP & IRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | UVSP | IRMD |
|---|---|---|
| Founded | 1876 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.2B |
| IPO Year | 1994 | 2014 |
| Metric | UVSP | IRMD |
|---|---|---|
| Price | $43.97 | $99.72 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | $36.67 | ★ $116.00 |
| AVG Volume (30 Days) | ★ 224.1K | 131.9K |
| Earning Date | 04-22-2026 | 05-01-2026 |
| Dividend Yield | ★ 2.44% | 0.95% |
| EPS Growth | ★ 21.32 | 16.67 |
| EPS | ★ 0.96 | 0.45 |
| Revenue | ★ $328,056,000.00 | $83,814,000.00 |
| Revenue This Year | $11.65 | $12.38 |
| Revenue Next Year | $4.77 | $11.31 |
| P/E Ratio | ★ $45.97 | $224.38 |
| Revenue Growth | 9.64 | ★ 14.43 |
| 52 Week Low | $27.91 | $55.11 |
| 52 Week High | $45.46 | $107.90 |
| Indicator | UVSP | IRMD |
|---|---|---|
| Relative Strength Index (RSI) | 65.18 | 70.57 |
| Support Level | $32.00 | $96.43 |
| Resistance Level | N/A | $105.87 |
| Average True Range (ATR) | 1.26 | 3.75 |
| MACD | 0.11 | 0.61 |
| Stochastic Oscillator | 73.62 | 98.60 |
Univest Financial Corp is engaged in domestic banking services for individuals, businesses, municipalities and non-profit organizations. The bank has three operating segments; Banking segment provides financial services including a full range of banking services such as deposit taking, loan origination, and servicing, mortgage banking, other general banking services, and equipment lease financing, Wealth Management segment offers investment advisory, financial planning, trust and brokerage services, and The Insurance segment includes a full-service insurance brokerage agency offering commercial property and casualty insurance, employee benefits solutions, personal insurance lines and human resources consulting. It generates majority of its revenue from the banking segment.
iRadimed Corp develops, manufactures, markets, and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system, which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates the majority revenue from United States.